Sutter Health Introduces First Fully Dissolving Heart Stent
Recently approved by FDA, the first-of-its-kind dissolving heart stent opens clogged arteries to restore blood flow, then gradually dissolves in the body
Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new treatment option, the Abbott Absorb stent, which literally disappears in the body over time.
Sailesh Shah, M.D., an interventional cardiologist at Sutter Medical Center and David Daniels, M.D., an interventional cardiologist at Mills-Peninsula will implant patients with the world’s first FDA-approved dissolving heart stent.
The Absorb bioresorbable vascular scaffold is a major advance in the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide despite decades of therapeutic advances.
While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in about three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants.
“This is the first real game-changer in coronary stents since 2003,when drug-coated metal stents were developed, helping to reduce risk of renarrowing of the arteries,” Dr. Daniels explained. “With dissolving stents you have the best of both worlds: you have the benefit of using a less invasive procedure than open heart surgery, and then the stent disappears, leaving no metal behind to restrict motion of the blood vessels.”
To ensure optimal patient selection and implant technique, Sutter’s interventional cardiology teams underwent extensive training on the new device. Dr. Daniels is one of a small group of physicians nationwide who train other interventional cardiologists on complex stenting procedures.
“The real benefit to the patient is better arterial health,” said Dr. Shah. “This new stent does not reduce bed rest or allow you to take fewer medicines, but it does promote better arterial health because you don’t have metal constricting your arteries and it facilitates the return of natural vascular function.” Dr. Shah occasionally returns to his native India to volunteer his time as a cardiologist, and began implanting the dissolving heart stent on patients there three years ago.
Sutter Health’s cardiovascular services bring together a multidisciplinary approach that provides the full continuum of cardiovascular care for our patients. More information about the Absorb dissolving heart stent is available online.
About Sutter Health
Serving patients and their families in more than 100 Northern California cities and towns, Sutter Health doctors, not-for-profit hospitals and other health care service providers share resources and expertise to advance health care quality and access. The Sutter Medical Network includes many of California’s top-performing, highest-quality physician organizations as measured annually by the Integrated Healthcare Association. Sutter-affiliated hospitals are regional leaders in cardiac care, women’s and children’s services, cancer care, orthopedics and advanced patient-safety technology. Sutter Health cares for more than 3 million people—nearly 1 percent of the U.S. population. For more information about the not-for-profit Sutter Health network visit: sutterhealth.org | facebook.com/sutterhealth | youtube.com/sutterhealth | twitter.com/sutterhealth
Communications Program Manager
Sutter Health Valley Area
Monique Binkley Smith
Manager, News Bureau
Sutter Health| Mills-Peninsula Health Services
 Absorb dissolves except for two pairs of tiny metallic markers that remain in the artery to enable a physician to see where the device was placed.
If you liked this article, you may also like:
Mills-Peninsula Begins Construction of Replacement Helipad Mills Receives Stroke Care Award Soul Stroll for Health May 21 Mills-Peninsula Announces New Treatment for Peripheral Artery Disease Kimberly Dalal, M.D., Elected to Commission on Cancer